Kench JG - Search Results

1

INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival.

Rynkiewicz NK, Fedele CG, Chiam K, Gupta R, Kench JG, Ooms LM, McLean CA, Giles GG, Horvath LG, Mitchell CA. Rynkiewicz NK, et al. Among authors: kench jg. Prostate. 2015 Jan;75(1):92-102. doi: 10.1002/pros.22895. Epub 2014 Oct 4. Prostate. 2015. PMID: 25284366

2

Low AZGP1 expression predicts for recurrence in margin-positive, localized prostate cancer.

Yip PY, Kench JG, Rasiah KK, Benito RP, Lee CS, Stricker PD, Henshall SM, Sutherland RL, Horvath LG. Yip PY, et al. Among authors: kench jg. Prostate. 2011 Nov;71(15):1638-45. doi: 10.1002/pros.21381. Epub 2011 Mar 22. Prostate. 2011. PMID: 21432866

3

Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer.

Bruce HM, Stricker PD, Gupta R, Savdie RR, Haynes AM, Mahon KL, Lin HM, Kench JG, Horvath LG. Bruce HM, et al. Among authors: kench jg. Prostate. 2016 Dec;76(16):1491-1500. doi: 10.1002/pros.23233. Epub 2016 Jul 30. Prostate. 2016. PMID: 27473574

4

Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.

Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL. Horvath LG, et al. Among authors: kench jg. Prostate. 2004 May 15;59(3):234-42. doi: 10.1002/pros.10361. Prostate. 2004. PMID: 15042598

5

Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.

Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM. Horvath LG, et al. Among authors: kench jg. Prostate. 2007 Jul 1;67(10):1081-90. doi: 10.1002/pros.20607. Prostate. 2007. PMID: 17476687

6

Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer.

Ho LL, Kench JG, Handelsman DJ, Scheffer GL, Stricker PD, Grygiel JG, Sutherland RL, Henshall SM, Allen JD, Horvath LG. Ho LL, et al. Among authors: kench jg. Prostate. 2008 Sep 15;68(13):1421-9. doi: 10.1002/pros.20809. Prostate. 2008. PMID: 18615486

7

Expression of phosphorylated-mTOR during the development of prostate cancer.

Sutherland SI, Pe Benito R, Henshall SM, Horvath LG, Kench JG. Sutherland SI, et al. Among authors: kench jg. Prostate. 2014 Sep;74(12):1231-9. doi: 10.1002/pros.22840. Epub 2014 Jul 7. Prostate. 2014. PMID: 25043667

8

Altered mitochondrial genome content signals worse pathology and prognosis in prostate cancer.

Kalsbeek AMF, Chan EKF, Grogan J, Petersen DC, Jaratlerdsiri W, Gupta R, Lyons RJ, Haynes AM, Horvath LG, Kench JG, Stricker PD, Hayes VM. Kalsbeek AMF, et al. Among authors: kench jg. Prostate. 2018 Jan;78(1):25-31. doi: 10.1002/pros.23440. Epub 2017 Nov 14. Prostate. 2018. PMID: 29134670

9

Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer.

Lin HM, Lee BY, Castillo L, Spielman C, Grogan J, Yeung NK, Kench JG, Stricker PD, Haynes AM, Centenera MM, Butler LM, Shreeve SM, Horvath LG, Daly RJ. Lin HM, et al. Among authors: kench jg. Prostate. 2018 Mar;78(4):308-317. doi: 10.1002/pros.23476. Epub 2018 Jan 5. Prostate. 2018. PMID: 29314097

10

Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death.

Birch SE, Kench JG, Takano E, Chan P, Chan AL, Chiam K, Veillard AS, Stricker P, Haupt S, Haupt Y, Horvath L, Fox SB. Birch SE, et al. Among authors: kench jg. Ann Oncol. 2014 Dec;25(12):2392-2397. doi: 10.1093/annonc/mdu454. Epub 2014 Sep 17. Ann Oncol. 2014. PMID: 25231954 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters